| 000 | 01900 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515165006.0 | ||
| 264 | 0 | _c20090728 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1556-1380 | ||
| 024 | 7 |
_a10.1097/JTO.0b013e31819f9a8a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLe Maître, Aurélie | |
| 245 | 0 | 0 |
_aAnticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group. _h[electronic resource] |
| 260 |
_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _cMay 2009 |
||
| 300 |
_a586-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xchemically induced |
| 650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
| 700 | 1 | _aDing, Keyue | |
| 700 | 1 | _aShepherd, Frances A | |
| 700 | 1 | _aLeighl, Natasha | |
| 700 | 1 | _aArnold, Andrew | |
| 700 | 1 | _aSeymour, Lesley | |
| 773 | 0 |
_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 4 _gno. 5 _gp. 586-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/JTO.0b013e31819f9a8a _zAvailable from publisher's website |
| 999 |
_c18790324 _d18790324 |
||